Sponsors

Chromogranin A enzyme-linked immunosorbent assay

Cisbio Bioassays has launched Chromoa, its chromogranin A enzyme-linked immunosorbent assay (ELISA) diagnostic tool. The new kit complements Cisbio’s existing chromogranin A radioimmunoassay (RIACT) kit and can be used by all laboratories for the detection and monitoring of neuroendocrine tumours.

Chromoa is a highly sensitive monoclonal antibody-based assay used to identify increased protein levels in serum when a neuroendocrine tumour is present. The most common neuroendocrine tumours affect the adrenal gland, the pancreas and the digestive track.

Chromogranin A is an increasingly essential analyte for the detection and monitoring of such tumours as well as prostate cancer, which can evolve into an aggressive neuroendocrine form.

Chromoa offers the same reliable results but in an ELISA format. This new kit features a longer shelf life and offers easier stock management, making it a convenient time- and cost-saving alternative. Particularly suitable for laboratories that do not use radioactive kits, ELISA methods have been used for quantitative analysis for several decades and can be adopted by any laboratory.

www.iba-worldwide.com

Latest Issues

2nd Global Summit on Pathology

Rome, Italy
10-11 April, 2025

The 10 Year Plan - Clinical Innovations Expo

Jubilee Hotel and Conference Centre, Nottingham, UK
15 May, 2025

Transforming Digital Pathology & AI: The Path Forward

Royal College Of Physicians Of Edinburgh
15 May, 2025

BSMT 40th Anniversary Microbiology Conference

RAF Museum, Hendon, London NW9 5LL
15 May, 2025

LabMedUK25

Bridgewater Hall, Manchester
9-11 June, 2025